Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about GILD
Recent news which mentions GILD
< Previous
1
2
...
25
26
27
28
29
30
31
32
Next >
This High-Risk, High-Reward Biotech Could Make COVID Less Deadly -- and Make Investors Money
August 04, 2021
Tickers
AVIR
GILD
MRK
RHHBY
Tags
MRK
RHHBY
AVIR
From
Motley Fool
$5,000 Invested in These 3 Healthcare Stocks Could Make You Rich Over the Next 10 Years
August 04, 2021
Tickers
ABBV
ARKG
GILD
ILMN
Tags
GILD
TDOC
NVTA
From
Motley Fool
Investors Should Avoid High-Risk Atossa Therapeutics
August 02, 2021
Tickers
AGNPF
ATOS
GILD
LLY
Tags
ATOS
Market News
GILD
From
InvestorPlace
Why Investors Should Like BioNTech's Latest Deal With Gilead
July 31, 2021
Tickers
ALPMY
BNTX
GILD
PFE
Tags
PFE
GILD
BNTX
From
Motley Fool
Gilead Sciences (GILD) Q2 2021 Earnings Call Transcript
July 30, 2021
Tickers
GILD
Tags
Market News
GILD
From
Motley Fool
The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam's Clinical Collaboration, 4 IPOs
July 30, 2021
Tickers
ABBV
ABSI
ACET
ALKS
Tags
BHVN
Penny Stocks
News
From
Benzinga
Gilead Sciences Exceeds Expectations As Remdesivir Success Cushions Slump In HIV Franchise
July 30, 2021
Tickers
GILD
Tags
Briefs
Covid/19
Benzinga
From
Benzinga
This 1 Thing in Pfizer's Earnings Report May be a Coronavirus Game Changer
July 30, 2021
Tickers
BNTX
GILD
PFE
Tags
PFE
Market News
BNTX
From
Motley Fool
Recap: Gilead Sciences Q2 Earnings
July 29, 2021
Tickers
GILD
Tags
Earnings
GILD
Benzinga
From
Benzinga
Sales of Gilead’s COVID-19 drug top $800 million
July 29, 2021
Tickers
GILD
Tags
GILD
From
MarketWatch
Eli Lilly-Incyte's Rheumatoid Arthritis Drug Gets OK From FDA For Solo Use In Hospitalized COVID-19 Patients
July 29, 2021
Tickers
GILD
INCY
LLY
Tags
Benzinga
INCY
Health Care
From
Benzinga
This Biotech Stock Is Too Cheap to Ignore
July 29, 2021
Tickers
ABBV
ALXO
GILD
IMAB
Tags
Market News
GILD
ALXO
From
Motley Fool
The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs
July 29, 2021
Tickers
ABBV
ABOS
ACET
AGIO
Tags
GMED
ETNB
RYTM
From
Benzinga
Think Carefully Before Speculating on Atossa Therapeutics
July 27, 2021
Tickers
ATOS
GILD
Tags
GILD
ATOS
Market News
From
InvestorPlace
A Look Into Gilead Sciences Price Over Earnings
July 27, 2021
Tickers
GILD
Tags
BZI/PE
Market News
Markets
From
Benzinga
Gilead Ordered To Pay Attorney Fees In Shareholder Lawsuit
July 26, 2021
Tickers
GILD
Tags
Health Care
Benzinga
Biotech
From
Benzinga
Understanding Gilead Sciences's Unusual Options Activity
July 26, 2021
Tickers
GILD
Tags
Markets
GILD
Market News
From
Benzinga
The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More
July 25, 2021
Tickers
ABBV
ACIU
AGIO
AGRX
Tags
CDNA
ITRM
PTCT
From
Benzinga
Why This Company’s Covid-19 Vaccine Is Just the Beginning
July 23, 2021
Tickers
BNTX
GILD
PFE
Tags
NASDAQ:BNTX,NYSE:PFE,NASDAQ:GILD
Market News
GILD
From
InvestorPlace
3 Biotechs That Could Make Big Acquisitions This Year
July 22, 2021
Tickers
ABBV
GILD
LLY
VRTX
Tags
XBI
Market News
ABBV
From
Motley Fool
The FDA may not fully approve a COVID-19 vaccine until January. Here’s why
July 21, 2021
Tickers
BNTX
GILD
JNJ
MRNA
Tags
JNJ
MRNA
BNTX
From
MarketWatch
Understanding Gilead Sciences's Unusual Options Activity
July 20, 2021
Tickers
GILD
Tags
Markets
GILD
Market News
From
Benzinga
Four-Year Biktarvy Data Show High Efficacy, Durable Viral Suppression In Untreated HIV Patients
July 19, 2021
Tickers
GILD
Tags
Biotech
Benzinga
Health Care
From
Benzinga
Gilead's Lenacapavir Shows High Rates Of Virologic Suppression In Heavily Treated HIV Patients
July 19, 2021
Tickers
GILD
Tags
General
HIV
GILD
From
Benzinga
2 Top Pharma Stocks to Buy Right Now
July 18, 2021
Tickers
GILD
JNJ
MRK
Tags
MRK
GILD
JNJ
From
Motley Fool
Analyzing Gilead Sciences's Unusual Options Activity
July 16, 2021
Tickers
GILD
Tags
Markets
GILD
Market News
From
Benzinga
Moderna Is Now More Valued Than Gilead, GlaxoSmithKline: How Long Did COVID-19 Vaccine Maker Take To Hit $100B?
July 15, 2021
Tickers
BNTX
GILD
GSK
MRNA
Tags
Market News
MRNA
BNTX
From
Benzinga
Investing $72,036 Into These 3 Stocks Can Generate $300 in Monthly Income for Your Portfolio
July 14, 2021
Tickers
GILD
MO
VZ
Tags
MO
VZ
Market News
From
Motley Fool
5 Stocks to Own for the Surge in Coronavirus Variants
July 14, 2021
Tickers
ABT
AMZN
BNTX
CVS
Tags
FLGT
WMT
LHDX
From
Motley Fool
Gilead's Remdesivir Fails To Show Antiviral Effects Against COVID-19 In Small WHO Study
July 13, 2021
Tickers
GILD
Tags
Market News
GILD
General
From
Benzinga
< Previous
1
2
...
25
26
27
28
29
30
31
32
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.